Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Renal Biomarkers Market Size?
The market size for renal biomarkers has experienced significant growth in the past few years. The projections indicate that it will expand from $1.28 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The growth during this past period can be traced back to factors such as a rise in kidney disease cases, advancements in medical diagnostics, an aging population, increased consciousness around early disease detection, the implementation of point-of-care testing, and a surge in chronic diseases.
The market size for renal biomarkers is anticipated to experience robust expansion in the forthcoming years. It is projected to reach $1.9 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.4%. Various factors contributing to this growth during the forecast period include personalized and targeted therapies, the inclusion of biomarker testing as a regularly-provided clinical service, the rise of emerging markets in Asia and Latin America, the use of non-invasive methodologies in biomarker testing, as well as continuous monitoring via wearable technologies. Key trends expected during the forecast period encompass multiplex biomarker panels for extensive disease profiling, the application of artificial intelligence and machine learning in biomarker identification, biomarker-focused companion diagnostics, point of care biomarker testing in the realm of home healthcare, and biomarkers used for early detection and preventive measures.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp
Which Demand Drivers Are Strengthening The Renal Biomarkers Market?
The increasing number of elderly and pediatric patients with kidney disease is predicted to stimulate the expansion of the renal biomarkers market. Elderly renal patients are those above 70 years old suffering from serious chronic kidney disease (CKD). On the other hand, pediatric patients with renal diseases are often diagnosed during their childhood or early adult life. Renal biomarkers are critical in assessing the damage extent in elderly and young kidney patients. For instance, the Australian Institute of Health and Welfare, a governmental agency based in Australia, reported in June 2024 that mortality rates for chronic kidney disease (CKD) had risen by 4.2% in 2021 and 6.2% in 2022. Thus, the growing numbers of elderly and pediatric kidney patients are fuelling the expansion of the renal biomarkers market.
What Segmentation Insights Are Provided In The Renal Biomarkers Market Research?
The renal biomarkersmarket covered in this report is segmented –
1) By Biomarker Type: Functional Biomarker; Up Regulated Protein; Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay; Particle-Enhanced Turbidimetric Immunoassay (PETIA); Colorimetric Assay; Chemiluminescent Enzyme Immunoassay (CLIA); Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring; Research Homecare
4) By End User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Functional Biomarker: Creatinine; Urea; Cystatin C; Bicarbonate
2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL); Kidney Injury Molecule-1 (KIM-1); Interleukin-18 (IL-18)
3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers; Acute Kidney Injury Biomarkers; Chronic Kidney Disease Biomarkers
Which Trends Are Likely To Redefine Growth Paths In The Renal Biomarkers Market?
The progression of technology has become a significant trend in the renal biomarkers market, with key industry players concentrating on cultivating groundbreaking technologies to maintain their market standing. For instance, the US-based Nipro Medical Corporation, a leader in the manufacturing of medical equipment, introduced SURDIAL DX in March 2022. The said system is a state-of-the-art hemodialysis device armed with advanced technology aiming for the utmost safety, convenience, and effectiveness for patients. It showcases modern design factors encompassing automated, simplified processes, ergonomic configuration, and a dedication to improve the overall experience of dialysis treatment.
Which Firms Are Driving Innovation Within The Renal Biomarkers Market?
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Renal Biomarkers Market?
North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7711&type=smp
Browse Through More Reports Similar to the Global Renal Biomarkers Market 2025, By The Business Research Company
Site Remediation Consulting Services Global Market Report 2025
Psoriasis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
Scientific Research And Development Services Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model